[In vitro blastic transformation of blood circulating lymphocytes. Dermatologic aspects].
D000937:Antigen-Antibody Reactions; D000941:Antigens; D001323:Autoantibodies; D001327:Autoimmune Diseases / Q000276:immunology; D009783:Dermatitis, Occupational / Q000276:immunology; D064420:Drug-Related Side Effects and Adverse Reactions; D004893:Erythema Nodosum / Q000276:immunology; D005455:Fluorescent Antibody Technique; D006650:Histocompatibility Testing; D006801:Humans; D007049:Iatrogenic Disease / Q000276:immunology; D066298:In Vitro Techniques; D037102:Lectins / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007938:Leukemia / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism; D008938:Mitosis; D012871:Skin Diseases / Q000276:immunology*; D012882:Skin Tests; D013290:Streptococcal Infections / Q000276:immunology; D013591:Syphilis, Cutaneous / Q000276:immunology; D014181:Transplantation Immunology; D014374:Tuberculin Test; D014382:Tuberculosis, Cutaneous / Q000276:immunology
D000941:Antigens; D001323:Autoantibodies; D037102:Lectins
La trasformazione blastica in vitro dei linfociti circolanti ematici. Aspetti dermatologici.